Natural Killer Cell (CYNK-001) Infusions in Adults With COVID-19

Clinical trial NCT04365101 · TERMINATED

Trial details

NCT number: NCT04365101
Sponsor: Celularity Incorporated
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Coronavirus Coronavirus Infection Severe Acute Respiratory Syndrome Coronavirus 2 Pneumonia Pneumonia, Viral Lung Diseases Respiratory Tract Disease Respiratory Tract Infections Coronaviridae Infections Nidovirales Infections RNA Virus Infections Virus Disease

Start date: 2020-09-02
Primary completion: 2021-08-30
Enrollment: 7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.